Oregon drug price transparency bill heads to Senate

Oregon's House of Representatives passed drug price transparency bill H.B. 4005 by a 46-14 vote. The bill now heads to the Senate.

The bill would require manufacturers to report information annually on drug prices, as well as development and marketing costs. Companies would report information on any drug with a wholesale acquisition cost (WAC) of at least $100 for a one-month supply, or for a therapy dosed for less than one month. Companies would also report price increases of 10% or more over a calendar year. Failure to report would be subject to a civil penalty...